Reaction
Thyroid Hormones Increased reporting signals
As of the last recalculation, Thyroid Hormones Increased appears in 1,039 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is CABOZANTINIB (PRR 49.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cabozantinib | 107 | 49.6 | 49.7 |
| Alemtuzumab | 33 | 35.3 | 35.3 |
| Thyroid, Porcine | 16 | 30.5 | 30.6 |
| Cimetidine | 10 | 21.0 | 21.0 |
| Lenvatinib | 30 | 18.8 | 18.9 |
| Pembrolizumab | 68 | 13.8 | 13.8 |
| Dorzolamide Hydrochloride And Timolol Maleate | 5 | 12.7 | 12.7 |
| Niraparib | 13 | 11.9 | 11.9 |
| Axitinib | 11 | 11.4 | 11.4 |
| Nivolumab | 51 | 11.1 | 11.1 |
| Lanreotide Acetate | 4 | 10.3 | 10.3 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 4 | 9.4 | 9.4 |
| Inclisiran | 3 | 7.5 | 7.5 |
| Apalutamide | 4 | 6.8 | 6.8 |
| Peginterferon Beta-1A | 4 | 6.1 | 6.1 |
| Relugolix | 6 | 5.1 | 5.1 |
| Adapalene | 5 | 0.5 | 0.5 |